(Q38003055)

26 August 2017

Pains in Parkinson disease--many syndromes under one umbrella (English)

1 reference

26 August 2017

1 reference

2

Günther Deuschl

0 references

author name string

Gunnar Wasner

series ordinal

1

1 reference

PubMed ID

22508236

26 August 2017

language of work or name

English

0 references

publication date

17 April 2012

1 reference

26 August 2017

Nature Reviews Neurology

1 reference

26 August 2017

8

1 reference

26 August 2017

5

1 reference

26 August 2017

284-294

1 reference

https://scigraph.springernature.com/pub.10.1038/nrneurol.2012.54

26 August 2017

0 references

cites work

Non-motor symptoms of Parkinson's disease: dopaminergic pathophysiology and treatment

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.54

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.54

Chronic pain in Parkinson's disease: the cross-sectional French DoPaMiP survey.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.54

The PRIAMO study: A multicenter assessment of nonmotor symptoms and their impact on quality of life in Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.54

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.54

Primary sensory symptoms in parkinsonism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.54

Pain in Parkinson's disease: Prevalence and characteristics

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.54

Quality of life and pain in Parkinson's disease: a controlled cross-sectional study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.54

Parkinson's disease symptoms: the patient's perspective.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.54

Pathophysiology of Parkinson's disease: from clinical neurology to basic neuroscience and back

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.54

The basal ganglia in Parkinson's disease: current concepts and unexplained observations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.54

Staging of brain pathology related to sporadic Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.54

Neuropathology of autonomic nervous system in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.54

A multisensory investigation of the functional significance of the "pain matrix".

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.54

The role of the basal ganglia in nociception and pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.54

Reward circuitry activation by noxious thermal stimuli

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.54

Direct activation of the ventral striatum in anticipation of aversive stimuli

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.54

High density of zinc-containing and dynorphin B- and substance P-immunoreactive terminals in the marginal division of the rat striatum

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.54

Analgesia induced by morphine injected into the pallidum

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.54

Bilateral intranigral microinjection of morphine and opioid peptides produces antinociception in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.54

Evidence that the substantia nigra is a component of the endogenous pain suppression system in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.54

Intensity-dependent nociceptive responses from presumed dopaminergic neurons of the substantia nigra, pars compacta in the rat and their modification by lateral habenula inputs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.54

A study of the connections of nociceptive substantia nigra neurones.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.54

Electrophysiological evidence for a somatotopic sensory projection to the striatum of the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.54

Inhibitory effects of substantia nigra on impulse transmission from nociceptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.54

An intracellular analysis of the entopeduncular inputs on the centrum medianum-parafascicular nuclear complex in cats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.54

Functional and structural imaging of pain-induced neuroplasticity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.54

Striatal dopamine D2 receptors in modulation of pain in humans: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.54

Striatal dopamine D2/D3 receptor availability correlates with individual response characteristics to pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.54

Effects of an intrathecal dopamine agonist, apomorphine, on thermal and chemical evoked noxious responses in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.54

Acute ipsilateral hyperalgesia and chronic contralateral hypoalgesia after unilateral 6-hydroxydopamine lesions of the substantia nigra.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.54

Altered sensorimotor integration in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.54

Spontaneous pain, pain threshold, and pain tolerance in Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.54

Neurophysiologic study of central pain in patients with Parkinson disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.54

Levodopa raises objective pain threshold in Parkinson's disease: a RIII reflex study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.54

Effect of levodopa on pain threshold in Parkinson's disease: a clinical and positron emission tomography study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.54

Apomorphine effect on pain threshold in Parkinson's disease: a clinical and positron emission tomography study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.54

Hyperalgesia and laser evoked potentials alterations in hemiparkinson: evidence for an abnormal nociceptive processing

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.54

Abnormal processing of the nociceptive input in Parkinson's disease: a study with CO2 laser evoked potentials

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.54

Influence of deep brain stimulation and levodopa on sensory signs in Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.54

Sensory deficit in Parkinson's disease: evidence of a cutaneous denervation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.54

Levodopa, methylmalonic acid, and neuropathy in idiopathic Parkinson disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.54

Neuropathy as a potential complication of levodopa use in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.54

Pain and motor complications in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.54

Parkinson's disease: the non-motor issues

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.54

Prevalence of chronic benign pain disorder among adults: a review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.54

Survey of chronic pain in Europe: Prevalence, impact on daily life, and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.54

Prevalence of chronic pain with neuropathic characteristics in the general population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.54

The Kyoto protocol of IASP Basic Pain Terminology

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.54

Neuropathic pain: redefinition and a grading system for clinical and research purposes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.54

Neuropathic pain: diagnosis, pathophysiological mechanisms, and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.54

21 January 2018

Central pain syndromes

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.54

Levodopa unresponsive symptoms in Parkinson disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.54

Striatal deformities of the hand and foot in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.54

Frozen shoulder and other shoulder disturbances in Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.54

Radicular and nonradicular back pain in Parkinson's disease: a controlled study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.54

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.54

The motor phenotype of Parkinson's disease in relation to age at onset.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.54

Autonomic dysfunctions in idiopathic Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.54

Pain in Parkinson's disease. Common yet seldom recognized symptom is treatable

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.54

Gastrointestinal motility problems in patients with Parkinson's disease. Effects of antiparkinsonian treatment and guidelines for management

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.54

Colonic biopsies to assess the neuropathology of Parkinson's disease and its relationship with symptoms

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.54

Central post-stroke pain: clinical characteristics, pathophysiology, and management

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.54

Exploring the relationship between Parkinson disease and restless legs syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.54

Sleep disorders, pain, and depression in Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.54

Rotigotine effects on early morning motor function and sleep in Parkinson's disease: a double-blind, randomized, placebo-controlled study (RECOVER).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.54

Review of the therapeutic management of Parkinson's disease. Report of a joint task force of the European Federation of Neurological Societies (EFNS) and the Movement Disorder Society-European Section (MDS-ES). Part II: late (complicated) Parkinson'

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.54

Review of the therapeutic management of Parkinson's disease. Report of a joint task force of the European Federation of Neurological Societies and the Movement Disorder Society-European Section. Part I: early (uncomplicated) Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.54

Chronic subthalamic deep brain stimulation improves pain in Parkinson disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.54

A randomized trial of deep-brain stimulation for Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.54

Deep brain stimulation: postoperative issues

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.54

Effect of chronic pallidal deep brain stimulation on off period dystonia and sensory symptoms in advanced Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.54

The evidence for pharmacological treatment of neuropathic pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.54

Effects of gabapentin on the motor response to levodopa: a double-blind, placebo-controlled, crossover study in patients with complicated Parkinson disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.54

Practice Parameter: evaluation and treatment of depression, psychosis, and dementia in Parkinson disease (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.54

Venlafaxine extended release in the treatment of painful diabetic neuropathy: a double-blind, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.54

Reduction of dyskinesia and induction of akinesia induced by morphine in two parkinsonian patients with severe sciatica

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.54

Macrogol 3350/electrolyte improves constipation in Parkinson's disease and multiple system atrophy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.54

Long-term treatment of restless legs syndrome with dopamine agonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.54

Current treatment options for restless legs syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.54

Quantitation of non-motor symptoms in Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.54

Reflex sympathetic dystrophy: changing concepts and taxonomy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.54

Quantitative sensory testing in the German Research Network on Neuropathic Pain (DFNS): Standardized protocol and reference values

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.54

A Survey of Pain in Idiopathic Parkinson's Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.54

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.54

Chapter 50 Pain in Parkinson's disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.54

Pain as a Nonmotor Symptom of Parkinson Disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.54

Sensory symptoms in Parkinson's disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.54

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.54

Fatty acid composition of the chronic subdural hematoma: with reference to its recurrence

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.54

Pain in Parkinson's Disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.54

Substantia nigra unit responses to trigeminal sensory stimulation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.54

Topographical organization of efferent projections from the cat substantia nigra pars reticulata

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.54

Afferent pathways to points of self-stimulation in the medial prefrontal cortex of the rat as revealed by the horseradish peroxidase technique

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.54

The involvement of dopamine in nociception: the role of D(1) and D(2) receptors in the dorsolateral striatum

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.54

Effects of cholinergic and dopaminergic agents on pain and morphine analgesia measured by three pain tests

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.54

Effects of dopaminergic agents on carrageenan hyperalgesia in rats

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.54

Dopamine reuptake inhibition in the rostral agranular insular cortex produces antinociception.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.54

Acute and long term effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in tests of nociception in mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.54

Quantitative measurement of pain sensation in patients with Parkinson disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.54

Pain sensitivity and descending inhibition of pain in Parkinson's disease.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.54

Facilitated temporal summation of pain at spinal level in Parkinson's disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.54

Oral and genital pain syndromes in Parkinson's disease.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.54

Joint and skeletal deformities in Parkinson's disease, multiple system atrophy, and progressive supranuclear palsy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.54

Shoulder pain in Parkinson's disease: a case-control study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.54

Shoulder pain: a presenting symptom of Parkinson disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.54

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.54

Back problems in Parkinson's disease: an underestimated problem

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.54

Evaluating back pain in older patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.54

Painful Parkinson's disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.54

Pain intensity on and off levodopa in patients with Parkinson's disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.54

Neck and other muscle pains in autonomic failure: their association with orthostatic hypotension.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.54

Gastrointestinal dysfunction in Parkinson's disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.54

Gastrointestinal symptoms in Parkinson disease: 18-month follow-up study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.54

Carpal tunnel syndrome in Parkinson's disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.54

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.54

Pain in depression and Parkinson's disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.54

Gabapentin for parkinsonism: a double-blind, placebo-controlled, crossover trial.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.54

An update on the dopaminergic treatment of restless legs syndrome and periodic limb movement disorder.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.54

Nocturnal subcutaneous apomorphine infusion in Parkinson's disease and restless legs syndrome.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.54

Methadone for refractory restless legs syndrome

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2012.54

31 March 2020

1 reference

12 December 2020

The effect of duloxetine on primary pain symptoms in Parkinson disease

1 reference

12 December 2020

1 reference

12 December 2020

[Sensory symptoms and pain in Parkinson disease]

1 reference

12 December 2020

1 reference

12 December 2020

When does Parkinson's disease begin?

1 reference

12 December 2020

Pain as a sequela of Parkinson disease

1 reference

12 December 2020

Prevalence and treatment of pain in older adults in nursing homes and other long-term care institutions: a systematic review

1 reference

12 December 2020

The 'marginal division': a new subdivision in the neostriatum of the rat

1 reference

12 December 2020

1 reference

12 December 2020

Foot dystonia in Parkinson's disease: clinical phenomenology and neuropharmacology

1 reference

12 December 2020

Back pain as an early symptom of Parkinson's disease

1 reference

12 December 2020

Depression in patients with Parkinson's disease

1 reference

12 December 2020

Identifiers

DOI

10.1038/NRNEUROL.2012.54

1 reference

PubMed ID

22508236

Dimensions Publication ID

26 August 2017

0 references

1 reference

PubMed ID

22508236